Nektar Announces Definitive Agreement with Ampersand Capital …

San Francisco, CA, November 4 th, 2024 – Nektar Therapeutics (Nasdaq: NKTR), a global biotechnology company focused on the discovery and development of novel therapies to treat …

$90
OFF

Nektar Therapeutics Sells Alabama Manufacturing Facility And …

2 weeks from now

Nov 7, 2024 · Nektar Therapeutics has agreed to sell its 24,000 square-foot commercial manufacturing site in Huntsville, Alabama, along with its reagent arm, to Ampersand for $90 …

talk.bio

$90
OFF

Nektar Divests Alabama Facility To Ampersand For $90 Million

2 weeks from now

Nov 4, 2024 · SAN FRANCISCO - Nektar Therapeutics (NASDAQ: NKTR), a biotech company specializing in autoimmune therapies, has agreed to sell its Huntsville, Alabama manufacturing operations to Ampersand Capital Partners.The transaction includes a $90 million total consideration, with $70 million in cash and a $20 million equity stake in a new Ampersand …

investing.com

$90
OFF

Nektar Divests Alabama Facility To Ampersand For $90 Million

2 weeks from now

Nov 4, 2024 · SAN FRANCISCO - Nektar Therapeutics (NASDAQ: NKTR), a biotech company specializing in autoimmune therapies, has agreed to sell its Huntsville, Alabama manufacturing …

investing.com

$90
OFF

Nektar Extends Cash Runway With $90M Manufacturing Plant Sale

2 weeks from now

Nov 4, 2024 · Nektar is selling its Alabama manufacturing plant and ... Under the agreement, Nektar is slated to receive $70 million in cash, plus a $20 million equity position in a new …

fiercepharma.com

8%
OFF

Nektar Sells Its PEGylation Reagent Manufacturing Business

2 weeks from now

Nov 5, 2024 · California, USA-based biotech Nektar Therapeutics’ (Nasdaq: NKTR) shares closed up more than 8% at $1.33 yesterday after it announced the sale of its only manufacturing …

thepharmaletter.com

FAQs about Nektar Announces Definitive Agreement with Ampersand Capital … Coupon?

Who is Nektar Therapeutics?

Nektar (NKTR) Therapeutics announced that it has entered into a definitive agreement to sell its Huntsville, Alabama manufacturing facility and reagent supply business to Ampersand Capital Partners, a Boston-based private equity firm. ...

Did ampersand buy Nektar?

Ampersand has agreed to acquire Nektar’s commercial-scale manufacturing facility and PEGylation reagent supply business for a total consideration of $90M, comprised of $70M in cash proceeds and $20M in a retained equity position for Nektar in a newly-created Ampersand portfolio company. ...

How much money did Nektar receive from a strategic divestment?

Nektar to receive $90 million in total consideration for the business, comprised of $70 million in cash and $20 million equity ownership in new portfolio company. Strategic divestiture allows Nektar to streamline its operations and continue its strategic focus on the development of core R&D programs in immunology. ...